Have a personal or library account? Click to login
Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development Cover

Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development

Acta Pharmaceutica
Volume 73 (2023): Issue 2 (June 2023)
By: Jurica Baranasic,  Yasmeen Niazi,  Subhayan Chattopadhyay,  Lada Rumora,  Lorna Ćorak,  Andrea Vukić Dugac,  Marko Jakopović,  Miroslav Samaržija,  Asta Försti and  Jelena Knežević  
Open Access
|Jun 2023
DOI: https://doi.org/10.2478/acph-2023-0019 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 243 - 256
Accepted on: Jan 9, 2023
Published on: Jun 12, 2023
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
GWAS,
SNP,
COPD,
lung cancer,
immune-related genes,
NF-κB
Related subjects:
Pharmacy,
Pharmacy, other

© 2023 Jurica Baranasic, Yasmeen Niazi, Subhayan Chattopadhyay, Lada Rumora, Lorna Ćorak, Andrea Vukić Dugac, Marko Jakopović, Miroslav Samaržija, Asta Försti, Jelena Knežević, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 73 (2023): Issue 2 (June 2023)Next article